Fredun Pharma

Fredun Pharmaceuticals received a CARE Ratings monitoring agency report on the use of proceeds from its ₹149.50 crore preferential issue for the quarters ended March 31 and June 30, 2026. CARE Ratings identified ₹13.21 crore of expenditure as not explicitly covered by the disclosed objects, including loan repayments, a flat purchase, fund-raising expenses, CSR, statutory dues and ₹1.50 crore of R&D spending for which supporting documents had not been provided. The agency also found a ₹2.65 crore difference in working-capital utilisation and said the company’s reported unutilised proceeds of ₹21.47 crore were below the ₹31.73 crore balance derived using its utilisation figure. Earlier monitoring reports had also recorded deviations or missing information, and the current report covered two quarters because Q4 details had not been received for the earlier report. Fredun said the expenditures fell within the broad approved objects and that it was reconciling the utilisation and unutilised-balance figures.

Powered by Tijori

Aug 5 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS LTD JUNE-QUARTER CONSOL PROFIT 131.3 MILLION RUPEES

• FREDUN PHARMACEUTICALS LTD JUNE-QUARTER CONSOL INCOME FROM OPERATIONS 2.28 BILLION RUPEES

Source text: ID:nBSE8GlBhX

Further company coverage: FRED.BO

(([email protected];))

May 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS MARCH-QUARTER CONSOL PROFIT 107.8 MILLION RUPEES

• FREDUN PHARMACEUTICALS MARCH-QUARTER CONSOL NET INCOME FROM OPERATIONS 2.1 BILLION RUPEES

• FREDUN PHARMACEUTICALS LTD - APPROVES BONUS ISSUE IN RATIO OF 2:1

Source text: ID:nBSE4lN1HZ

Further company coverage: FRED.BO

(([email protected];))

April 29 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS - EXPANDS MANUFACTURING BASE WITH FIFTH FACILITY AT PALGHAR

• FREDUN PHARMACEUTICALS - NEW FACILITY EXPECTED TO BE OPERATIONAL BY OCTOBER 2026

Source text: ID:nBSE46TGHd

Further company coverage: FRED.BO

(([email protected];))

Feb 9 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS DEC-QUARTER CONSOL PROFIT 104.8 MILLION RUPEES

• FREDUN PHARMACEUTICALS DEC-QUARTER CONSOL INCOME FROM OPERATIONS 1.6 BILLION RUPEES

Source text: ID:nBSE52Blzf

Further company coverage: FRED.BO

(([email protected];))

Sept 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS LTD - TO ISSUE 652,360 EQUITY SHARES

• FREDUN PHARMACEUTICALS LTD - TO ISSUE 573,600 CONVERTIBLE WARRANTS

• FREDUN PHARMACEUTICALS - EQUITY SHARES TO BE ISSUED AT 1,250 RUPEES PER SHARE

• FREDUN PHARMACEUTICALS LTD - SHARE WARRANTS TO BE ISSUED AT 1,250 RUPEES PER WARRANT

Source text: ID:nBSE48CVlF

Further company coverage: FRED.BO

(([email protected];;))

July 10 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS LTD - COMPANY RECEIVES SEBI ADJUDICATION ORDER

• FREDUN PHARMACEUTICALS LTD - NO MONETARY PENALTY IMPOSED BY SEBI

Source text: ID:nBSEbkxlxJ

Further company coverage: FRED.BO

(([email protected];;))

** Shares of Fredun Pharmaceuticals FRED.BO climb 2.6% to 832 rupees

** The benchmark Nifty 50 .NSEI was down 0.5% on profit-taking in heavyweight financials

** Pharma firm forays into pet-care market on acquiring One Pet Stop, which has a costumer base of 4,000 pet owners

** Stock up ~13% YTD

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

April 9 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• AWARDED A SIGNIFICANT TENDER BY TAMIL NADU MEDICAL SERVICES CORP

• TENDER VALUE BETWEEN 150 MILLION RUPEES AND 180 MILLION RUPEES

Source text: ID:nBSE77QdFx

Further company coverage: FRED.BO

(([email protected];;))

March 18 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS LTD - PHARMA ANNOUNCES INTERNATIONAL EXPANSION OF FREOSSI DIVISION

• FREDUN PHARMACEUTICALS LTD - PHARMA INTRODUCES 9 PREMIUM PETCARE PRODUCTS IN SRI LANKA

Source text: ID:nBSE533f4B

Further company coverage: FRED.BO

(([email protected];))

Feb 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS - INSTALLS SECOND ITALIAN TUBE FILLING MACHINE

• FREDUN PHARMACEUTICALS - INVESTMENT BOOSTS PRODUCTION CAPACITY BY 2.9 TIMES

Source text: ID:nBSE5BqF4w

Further company coverage: FRED.BO

(([email protected];))

Oct 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• APPROVED ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 10 MILLION

• MAY ISSUE FURTHER FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 2 MILLION

Source text for Eikon: ID:nBSE7dkdxL

Further company coverage: FRED.BO

(([email protected];;))

Sept 26 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• FREDUN PHARMACEUTICALS - TO CONSIDER ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS

Source text for Eikon: ID:nBSEb7K6YQ

Further company coverage: FRED.BO

(([email protected];))

Feb 12 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• SECURES ORDERS FROM SEA COUNTRIES

• ORDERS WORTH 280 MILLION RUPEES

• EXPANDS PRODUCT DEVELOPMENT IN VETERINARY CARE, ADVANCES ORTHOPAEDIC APPLICATIONS

Source text for Eikon: ID:nBSEDCn96

Further company coverage: FRED.BO

(([email protected];))

Dec 21 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• DAULAT NARIMAN MEDHORA REAPPOINTED AS WHOLE TIME DIRECTOR DESIGNATED AS JOINT MANAGING DIRECTOR

Further company coverage: FRED.BO

(([email protected];))

Dec 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• TO CONSIDER A PROPOSAL FOR FUND RAISING

• TO CONSIDER A PROPOSAL FOR FUND RAISING WORTH UPTO 1.2 BILLION RUPEES

Source text for Eikon: ID:nBSE8bp1rl

Further company coverage: FRED.BO

(([email protected];))

Nov 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• RE-APPOINTS FREDUN MEDHORA AS MD

Source text for Eikon: ID:nBSE5KFFg9

Further company coverage: FRED.BO

(([email protected];))

July 19 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• JUNE-QUARTER NET PROFIT 24 MILLION RUPEES VERSUS PROFIT 9.4 MILLION RUPEES

• JUNE-QUARTER INCOME FROM OPERATIONS 612.3 MILLION RUPEES VERSUS 481.3 MILLION RUPEES

Source text for Eikon: ID:nBSE1BDGBw

Further company coverage: FRED.BO

(([email protected];))

May 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:

• MARCH-QUARTER PROFIT 38.9 MILLION RUPEES VERSUS 23 MILLION RUPEES YEAR AGO

• MARCH-QUARTER TOTAL INCOME FROM OPERATIONS 798 MILLION RUPEES VERSUS 718.5 MILLION RUPEES YEAR AGO

Source text for Eikon: ID:nBSEb7lWKb

Further company coverage: FRED.BO

(([email protected];))